People with diabetes suffer from depression more frequently than average. Researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (Forschungsinstitut an der Diabetes Akademie Mergentheim, FIDAM) and the German Center for Diabetes Research (DZD) were able to show in a large-scale analysis that biomarkers for chronic inflammation levels influence the therapeutic success of depressive symptoms—however, with considerable differences in type 1 and type 2 diabetes. The findings could help to customize the treatment of depression in people with diabetes in the future.
This article was originally published on MedicalXpress.com
